Showing results (1631-1640 of 1,768) with videos related to
Sort By:
Pageof 177
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 21, 2018
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor ModelJulius W Kim, J Robert Kane, Wojciech K Panek, et al.Aquatic Toxicology (Amsterdam, Netherlands)|November 5, 2022
Comparison of transcriptome responses of the liver, tail fin, and olfactory epithelium of Rana [Lithobates] catesbeiana tadpoles disrupted by thyroid hormones and estrogenShireen H Jackman, Ellis P Evans, Haley N Kuecks-Winger, et al.The American Journal of Tropical Medicine and Hygiene|February 4, 2015
An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaquesStefan Fernandez, Stephen J Thomas, Rafael De La Barrera, et al.Molecular Therapy. Nucleic Acids|January 31, 2024
Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression <i>in vitro</i> and <i>in vivo</i>Elena M Smekalova, Maria G Martinez, Emmanuel Combe, et al.Nature Communications|July 1, 2018
Pervasive genetic interactions modulate neurodevelopmental defects of the autism-associated 16p11.2 deletion in Drosophila melanogasterJanani Iyer, Mayanglambam Dhruba Singh, Matthew Jensen, et al.Clinical Breast Cancer|May 17, 2011
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trialNicholas J Robert, Mansoor N Saleh, Devchand Paul, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials GroupM N Levine, V H Bramwell, K I Pritchard, et al.The Journal of Investigative Dermatology|August 31, 2012
Interferon regulatory factor 6 promotes differentiation of the periderm by activating expression of Grainyhead-like 3Gabriel de la Garza, Jack Robert Schleiffarth, Martine Dunnwald, et al.Human Molecular Genetics|December 11, 2012
Copy number variation analysis implicates the cell polarity gene glypican 5 as a human spina bifida candidate geneAlexander G Bassuk, Lakshmi B Muthuswamy, Riley Boland, et al.American Journal of Respiratory and Critical Care Medicine|April 23, 2016
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense MutationsVenkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.Pageof 177